MichaelJamesFergusonMD
Pediatric Hematology & Oncology • Louisville, KYAssociate Professor of Pediatrics, Indiana University School of Medicine
Dr. Ferguson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
411 E Chestnut St
# 4B
Louisville, KY 40202Phone+1 502-588-3600Fax+1 502-588-9536
Summary
- Medical Director, Solid Tumor Program
Medical Director, Pediatric Cancer Precision Genomics Program
Education & Training
Indiana University School of MedicineFellowship, Clinical Pharmacology, 2012 - 2014- Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2010 - 2013
- Indiana University School of MedicineResidency, Pediatrics, 2007 - 2010
- Indiana University School of MedicineClass of 2007
Certifications & Licensure
IN State Medical License 2010 - 2025
KY State Medical License 2024 - 2025- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors Start of enrollment: 2017 Dec 28
- Pharmacokinetics, Safety and Efficacy of the Selumetinib Granule Formulation in Children Aged ≥1 to <7 Years With NF1-related Symptomatic, Inoperable PN Start of enrollment: 2022 Jan 21
Roles: Contact
Publications & Presentations
PubMed
- 6 citationsPrecision Medicine Highlights Dysregulation of the CDK4/6 Cell Cycle Regulatory Pathway in Pediatric, Adolescents and Young Adult Sarcomas.Farinaz Barghi, Harlan E Shannon, M Reza Saadatzadeh, Barbara J Bailey, Niknam Riyahi
Cancers. 2022-07-25 - 2 citationsEarly administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromat...Amy E. Armstrong, Steven D. Rhodes, Abbi Smith, Shi Chen, Waylan K. Bessler
Pediatric Blood & Cancer. 2020-08-01 - 7 citationsEmerging molecular-targeted therapies in early-phase clinical trials and preclinical models.Michael J. Ferguson, Pooja Hingorani, Abha A. Gupta
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 2013-05-16
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
